Levitee (LVT) Pharmacies increased revenue by 10 per cent in one month.
On a consolidated basis, Levitee has recorded an unaudited revenue of $893, 863 for the month of August. This increase in revenue has been driven by Levitee's recent acquisition of ACT Medicals.
Earth Circle Organics, Levitee’s direct-to-consumer and wholesaler of supplements and superfood products increased its sales by 14.5 per cent. This was made possible through further scaling of their direct-to-consumer business and introducing a multidisciplinary component to Levitee Labs’ healthcare assets and incorporating new mental health and treatment patterns.
Founder and CEO of the company, Pouya Farmand, talks about the company’s success and moving forward.
“The company is successfully executing on its strategic plan to innovate internally, accelerate growth through cross-sales opportunities, and make strategic value acquisitions on an opportunistic basis. We have put a strong emphasis on the continued growth of recurring revenues,” says Farmand.
Levitee will look to build more on its fast-growing expansion plans for the next 12 months. The core focus for Levitee is to generate revenue by taking advantage of profitable business investments, increasing margins, further developing its portfolio of assets through organic growth and other major growth opportunities that become available in the market.
Levitee Labs is a leader in the integrative wellness space. It aims to transform mental health and addiction treatments through the integration of psychedelic medicines and therapies into a medical home care model.
Levitee (LVT) is up 1.06 per cent today, and is trading at C$0.48 per stock as of 10:50 a.m. ET.